miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells

Doxorubicin is conventionally used in chemotherapy against hepatocellular carcinoma (HCC), but acquired resistance developed during long-term therapy limits its benefits. Autophagy, a conserved catabolic process for cellular self-protection and adaptation to the changing environment, is regarded as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Death Dis
Main Authors: Zhou, Yue, Chen, Enjiang, Tang, Yuexiao, Mao, Jiayan, Shen, Jian, Zheng, Xiaoxiao, Xie, Shangzhi, Zhang, Shufen, Wu, Ying, Liu, Hao, Zhi, Xiao, Ma, Tao, Ni, Haibin, Chen, Jiabin, Chai, Kequn, Chen, Wei
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834650/
https://ncbi.nlm.nih.gov/pubmed/31695022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-2053-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki